Domestic share of approved innovative biological products
Proportion of approved innovative biological medicines accounted for by domestic developers.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
2 records · 1 region · 2025
Primary documents
Sources
2 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 2025年我国批准创新药76个 对外授权超千亿美元 | MOFCOM | — | 1 |
| 国家医疗保障局 医保动态 创新高！去年我国批准创新药76个 对外授权破千亿美元 | NHSA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Domestic share of approved innovative biological products. Retrieved from https://statorigin.org/indicators/domestic-share-of-approved-innovative-biological-products